067370 — Sun Bio Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩96bn
- KR₩112bn
- KR₩12bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 741 | 1,202 | 285 | 869 | 4,607 |
Depreciation | |||||
Non-Cash Items | 478 | 566 | 4,512 | 2,202 | 1,186 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,300 | -304 | -2,194 | -2,235 | -1,763 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 758 | 2,310 | 3,479 | 1,639 | 4,969 |
Capital Expenditures | -159 | -115 | -4,477 | -18,786 | -8,609 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -7,640 | -7 | 7,767 | -9,955 | 9,965 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -7,799 | -122 | 3,291 | -28,741 | 1,356 |
Financing Cash Flow Items | — | — | -11.8 | 240 | 245 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 7,225 | -477 | -2,957 | 21,712 | -1,674 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 152 | 1,710 | 4,032 | -5,446 | 4,651 |